In TSC, the growth of benign tumors in various organs occurs from loss of TSC1 or TSC2 genes and subsequent overactivation of mammalian target of rapamycin (mTOR), a kinase responsible for regulating cell growth, proliferation, and angiogenesis [1,3,4]. This evidence concerns the gene TSC1 and benign neoplasm.